• 566 Citations
  • 10 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

My current research is focused on expanding the chemical toolbox for neural signaling and anti-inflammation/anti-oxidant pathways to help us understand the mechanism of action of the disease pathology associated with glaucomatous optic neuropathy, Alzheimer’s Diseases, Ischemic stroke, and angiogenesis. Our lab integrates medicinal chemistry, chemical biology, bio-engineering, and drug delivery using nanotechnology. We employ synthetic organic and organometallic chemistry to generate a small molecule library for low throughput as well as high throughput screening (target based as well as phenotypic). The ultimate goal of my lab is to produce novel therapeutic molecules which can be progressed to human clinical trials for these diseases.

Education/Academic qualification

PhD in Organic Chemistry, CSIR Indian Institute of Chemical Technology

Fingerprint Dive into the research topics where Suchismita Acharya is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Aldehydes Medicine & Life Sciences
Ethers Chemical Compounds
Copper Medicine & Life Sciences
Esters Chemical Compounds
Lewis Blood-Group System Medicine & Life Sciences
High Pressure Liquid Chromatography Medicine & Life Sciences
Sterol Regulatory Element Binding Proteins Medicine & Life Sciences
Alcohols Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2020

Research Output 1996 2019

  • 566 Citations
  • 10 h-Index
  • 17 Article

Hybrid compound sa-2 is neuroprotective in animal models of retinal ganglion cell death

Stankowska, D. L., Dibas, A., Li, L., Zhang, W., Krishnamoorthy, V. R., Chavala, S. H., Nguyen, T. P., Yorio, T., Ellis, D. Z. & Acharya, S., Jul 2019, In : Investigative Ophthalmology and Visual Science. 60, 8, p. 3064-3073 10 p.

Research output: Contribution to journalArticle

Open Access
Retinal Ganglion Cells
Cell Death
Nerve Crush
Animal Models
2 Citations (Scopus)

Novel Chitohexaose Analog Protects Young and Aged mice from CLP Induced Polymicrobial Sepsis

Das, P., Panda, S. K., Agarwal, B., Behera, S., Ali, S. M., Pulse, M. E., Solomkin, J. S., Opal, S. M., Bhandari, V. & Acharya, S., 1 Dec 2019, In : Scientific Reports. 9, 1, 2904.

Research output: Contribution to journalArticle

Open Access
6 Citations (Scopus)

Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases

Le, D. Q., Kuriakose, A. E., Nguyen, D. X., Nguyen, K. T. & Acharya, S., 1 Dec 2017, In : Scientific Reports. 7, 1, 8692.

Research output: Contribution to journalArticle

Nitric Oxide Donors
Peripheral Arterial Disease
Nitric Oxide
Endothelial Cells
5 Citations (Scopus)
Optic Nerve Diseases
Photoreceptor Cells
18 Citations (Scopus)

Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity

Feng, Z., Acharya, S., Klimko, P. G., Hellberg, M. R., May, J. A., Kelly, C., Williams, G., McLaughlin, M. A. & Sharif, N. A., 1 Jun 2007, In : Bioorganic and Medicinal Chemistry Letters. 17, 11, p. 2998-3002 5 p.

Research output: Contribution to journalArticle

Serotonin 5-HT2 Receptor Agonists
Receptor, Serotonin, 5-HT2A
Ophthalmic Administration